In particular, people age 65 and older may be susceptible to distinct risks including muscle mass loss when taking GLP-1s and similar drugs
Our data demonstrated that SVV-induced inflammatory effects are associated with ferroptosis
Due to the similar molecular mechanism between T2DM and AD, several drugs for the treatment of T2DM are increasingly being proposed for the treatment of AD (15, 82)
However, semaglutides like Ozempic and Wegovy as well as tizepatide (Mounjaro) can cause fatigue and somnolence (drowsiness)
As Phase 3 data becomes available, these protocols may be refined based on larger population data
Other GLP-1 receptor agonists, such as liraglutide (Saxenda), use a different dosing schedule (daily rather than weekly) and may be better tolerated by some individuals, though gastrointestinal side effects remain common across this drug class